SCHEDULE 13D/A: Coliseum Capital Reduces Stake in Universal Technical Institute Below 5% Threshold

Coliseum Capital Management and its affiliates have significantly reduced their beneficial ownership in Universal Technical Institute, Inc., falling below the 5% reporting threshold with a block sale of 500,000 shares.

Summary

• Coliseum Capital Management, LLC and its affiliated entities (Coliseum Capital, LLC, Coliseum Capital Partners, L.P., Adam Gray, and Christopher Shackelton) filed Amendment No. 12 to their Schedule 13D for Universal Technical Institute, Inc.
• On May 27, 2025, Coliseum Capital Partners, L.P. executed a block sale of 414,513 shares of Common Stock, and a separate account investment advisory client of Coliseum Capital Management, LLC sold 85,487 shares.
• Both block sales were executed at a price of $35.00 per share.
• Following these transactions, the Reporting Persons collectively ceased to be beneficial owners of more than five percent of Universal Technical Institute, Inc.'s Common Stock.
• This filing represents the final amendment to their Schedule 13D, serving as an exit filing for the Reporting Persons.
• As of May 1, 2025, there were 54,406,215 shares of Common Stock outstanding.
• Current beneficial ownership: Coliseum Capital Management, LLC, Adam Gray, and Christopher Shackelton now beneficially own 2,716,267 shares (4.99%). Coliseum Capital, LLC and Coliseum Capital Partners, L.P. now beneficially own 2,251,855 shares (4.1%).

Sentiment

Score: 5

Explanation: The sentiment is neutral from the company's perspective as it's an investor's exit filing, not a company announcement. For the investor, it's a completed transaction at a specific price. The market reaction to a large block sale could be negative, but the document itself is factual and reports a completed action.

Negatives

• A significant institutional investor, Coliseum Capital, has reduced its stake in Universal Technical Institute, Inc. below the 5% threshold, which could be interpreted by the market as a reduction in conviction or a strategic portfolio reallocation.
• The block sale of 500,000 shares by a major holder could exert downward pressure on the stock price, especially if the market perceives it as a lack of confidence or a precursor to further divestment.

Future Outlook

The document does not provide any forward-looking statements or guidance from Universal Technical Institute, Inc. It solely reports a change in beneficial ownership by a specific investor group.

Industry Context

This filing reflects a significant portfolio adjustment by Coliseum Capital, a known institutional investor, regarding its stake in Universal Technical Institute, Inc. While the document itself does not provide broader industry context, a large divestment by a long-term investor could be interpreted by the market as a signal, potentially influencing investor sentiment towards the education or vocational training sector, depending on the reasons for the sale (which are not disclosed in this filing).

Stakeholder Impact

• **Shareholders**: The sale of a significant block of shares by a major investor could lead to increased trading volume and potential short-term price volatility. Existing shareholders might interpret the divestment as a loss of institutional confidence, potentially impacting their investment decisions.
• **Company (Universal Technical Institute, Inc.)**: While the direct impact on operations is minimal, the reduction of a long-term institutional investor's stake could affect investor relations and market perception, potentially influencing future capital-raising efforts or valuation.

Next Steps

• This Amendment No. 12 is stated to be the final amendment to the Initial 13D, constituting an exit filing for the Reporting Persons, meaning no further Schedule 13D amendments are expected from these specific entities regarding their stake in Universal Technical Institute, Inc. unless their beneficial ownership again exceeds 5%.

Key Dates

Recommendation

Keywords

Universal Technical Institute, UTI, Coliseum Capital Management, Coliseum Capital, Schedule 13D, SEC filing, beneficial ownership, stock sale, institutional investor, exit filing, common stock